Functional Neuromodulation

Functional Neuromodulation Ltd. is investigating the use of deep brain stimulation of the fornix (DBS-f) to drive neural activity and modulate the brain’s memory circuit. The company completed a Phase II multi-center clinical trial of DBS-f in 42 patients with mild probable Alzheimer’s. Functional Neuromodulation is dedicated to advancing the application of deep brain stimulation (DBS) therapies to help improve the lives of people with mild Alzheimer’s disease. CAUTION — Investigational device. Limited by Federal law to investigational use

网站

https://www.fxneuromod.com

Functional Neuromodulation的外部链接

所属行业

医疗设备制造业

规模

2-10 人

总部

Minneapolis

类型

私人持股

创立

2011

领域

neuromodulation、deep brain stimulation、Alzheimer's disease、DBS、clinical studies、clinical trials、clinical research、dementia、neurology、neurosurgery、Mild Alzheimer's Disease、Alzheimer's Research、Alzheimer's Trial和Alzheimer's Study